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SUMMARY
Selenium (Se) is an unusual metalloid of considerable interest from both a toxicological and a nutritional perspective, with a very narrow
safe range of intake. Although there are many reports about its detoxification properties, toxicity aspects of it have also been tracked for
several decades. Lots of studies demonstrated that low Se is an efficacious avail whereas high Se can induce toxicity and the significant
toxicity of selenium emphasizes the need to assess the health risk of various selenocompounds as nutritional supplements. The toxicity of
different forms and compounds of selenium is also summarized in this review. 
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ÖSSZEFOGLALÁS
A szelén (Se) egy nem szokványos félfém, mely iránt komoly érdeklődés mutatkozik mind toxikológiai, mind pedig táplálkozási szempont-
ból. A szelén biztonságos beviteli mennyisége ugyanakkor nagyon korlátozott. Bár sokan vizsgálták a detoxifikációs tulajdonságait, a szelén
toxikusságát szintén jónéhány évtizede kutatják. Számos tanulmány mutatott rá, hogy az alacsony szelénbevitel hatékony lehet, a nagyarányú
bevitel azonban toxikus hatású, mely szükségessé teszi a különféle táplálékkiegészítőként alkalmazott szelénvegyületek egészségi kockázatá-
nak felmérését. Ez a tanulmány tartalmazza a szelén különféle formáinak és vegyületeinek toxicitási adatait is.  
Kulcsszavak: toxicitás, szelénforma, szelénvegyület
INTRODUCTION
Selenium is a member of the non-metallic elements
within group VIa of the periodic table. It has an atomic
number of 34, an atomic weight of 78.96, and has six
different naturally occurring stable isotopic masses
from 74 to 82 (Rosman and Taylor, 1997). Selenium
has four natural oxidation states: -2 (selenides), 0
(elemental), +4 (selenites), and +6 (selenates) (Barceloux,
1999). Selenium was ﬁrst identiﬁed in 1817 by Jons
Jakob Berzelius, a Swedish chemist, who investigated
worker illnesses in a sulfuric acid plant at Gripsholm,
Sweden (Fredga, 1972). He named this element after
“Selene”, the green moon Goddess. 
Selenium toxicity was first confirmed in 1933 to
occur in livestock that consumed plants of the genus
Astragalus, Xylorrhiza, Oonopsis, and Stanleya in the
western regions of the United States (Spallholz, 1994). 
Cases of selenium poisoning are usually a result of
one of three types of exposure history. First, grazing
animals ingest forages that have accumulated selenium
in higher concentrations than normal from seleniferous
soils. Second, selenium toxicity is from environmental
contamination from agricultural drain water, reclaimed
soils from phosphate or ore mining, sewage sludge or fly
ash. Third, selenosis is caused by accidental overdoses
by injection of selenium supplements or by misformulation
of feed mixes. Each of these poisoning may be observed
subacute, acute or chronic selenosis depending on the
daily dose and duration of exposure (Zane Davis and
Hall, 2011).
TOXICITY OF SELENIUM FORMS AND COMPOUNDS
Elemental selenium is insoluble in aqueous media
and is considered biologically inert. Elemental selenium
and most metallic selenides have relatively less toxicity
because of the low bioavailability, which on the other
hand limited their utility in feed and food nutritional
supplementation. By contrast, selenates, selenites and
organoselenium compounds, such as selenomethionine
(SeMet), selenocysteine and methylselenocysteine are
widely used as nutritional selenium source but they
are all toxic in higher doses. In general, SeMet and
SeMet enriched yeast are more effective for increasing
human and animal selenium levels and less toxic than
inorganic selenium. The reason may lie on the non-
specific incorporation of selenomethionine into proteins
and providing reversible selenium storage in organs
and tissues (Schrauzer, 2003).
However, the excessive incorporation can also lead
to structural malformation or loss of enzymatic activ-
ity in some sulfur-containing proteins due to the re-
placement of sulfur in sulfhydryl groups or thiols
(critical for disulfide bond formation) with selenium
(Stadtman, 1990).
Se-methylselenocysteine (SeMC), another naturally
occurring organoselenium compound was firstly identified
in Astragalus bisulcatus (Trelease et al., 1960) and later
found in many other plants (Lyi et al., 2005; Freeman
et al., 2012), was reported to be less toxic and more
bioactive than inorganic or other organic selenium
compounds (Hoefig et al., 2011). Because SeMC is not
readily incorporated into proteins and accumulates in a
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free pool after ingestion, it has been considered a better
form of nutritional selenium supplements (neuhierl
and Bock, 1996). In addition, recent studies indicated
that SeMC conferred remarkable protection against
breast cancer (Ip et al., 2000; El-Bayoumy and Sinha,
2004; Unni et al., 2005; Zhang and Zarbl, 2008),
prostate cancer (Zhang et al., 2010; Sinha et al., 2014)
and colorectal carcinoma (Cao et al., 2014). SeMC can
be a similar or better selenium source than SeMet and
supplies methylselenol, an active metabolite recognized
essential for the anticancer effect (Ip et al., 2002; Zhan
et al., 2013), much more efficiently in organs than
SeMet (Suzuki et al., 2006). It is promising that SeMC
can be developed as a pharmaceutical drug that can be
used in chemoprevention and clinical intervention of
human cancers. However, a common concern in the
uses of SeMC either for nutritional supplementation or
for cancer chemoprevention is the safety risk rising
from significant toxicity of selenium, and this has not
been well elucidated yet.
Two common inorganic forms of selenium (selenite
and selenate) are important in biogeological and
biochemical cycle of Se, but they have different
biochemical properties. For example, their toxicity and
energy consumption during uptake and metabolism are
different (Shen et al., 1997; Weiller et al., 2004).
Selenite is generally more toxic than selenate in
aquatic environment (Eisler, 2007). On the other hand,
selenate proved to be more toxic than selenite to soil
animals (Somogyi et al., 2007).
SELENIUM TOXICITY IN PLANTS
Selenium occurs in the earth’s crust most commonly
as selenite, selenate and selenides associated with
sulphide minerals (nRC, 1983). Many factors dictate
the concentration of selenium in plants including but
not limited to the type of vegetation, chemical form of
selenium in the soil, pH of soil, moisture content of soil
and the concentration of selenium in the soil. Selenium
is commonly found as water-soluble selenate in well-
aerated, alkaline soils and is readily absorbed via the
sulphate transporter system by plants, as compared to
very poor uptake of selenides and selenite. Some soils
also contain selenomethionine from decay of selenium
containing vegetation which also is taken up by some
plants (Marschner, 1995). 
Soils containing high concentrations of selenium are
commonly found in many parts of the world. Many areas
within the northern Great Plains of the United States,
such as the Dakotas, Wyoming, Montana, nebraska, and
Kansas, have high soil selenium content (4–5 mg kg-1
Selenium or more), resulting in high level of plant uptake
and subsequent Se toxicosis in herbivores (Rosenfeld and
Beath, 1964). Seleniferous soils are often characterized
by alkaline soils that were developed from shales and are
located in arid or semi-arid climates. In north America
seleniferous soils and forages with high concentrations
of selenium have been found in western Canada, Arizona,
Colorado, Idaho, Kansas, nevada, north Dakota, South
Dakota, new Mexico and Oklahoma. High soil selenium
also occurs in alkaline soils of some localities in Algeria,
Argentina, Australia, Bulgaria, Canada, China, Columbia,
Ireland, Israel, Mexico, Morocco, new Zealand, South
Africa, the former Soviet Union, Spain, and Venezuela
(nRC, 1983). However, total soil selenium is not the best
indicator of potential selenium poisonings, as Hawaii
and Puerto Rico have areas of high soil selenium that is
not available to the plants due to the acidic soil types,
which result in lowered water soluble, bioavailable
selenium for plant uptake (Lakin, 1961).
Areas that contain soils high in available selenium
are often identified by the presence of obligate indicator
plants that require high selenium for survival; including
Astragalus spp., Oonopsis spp., Stanleya pinnata and
Xylorrhiza spp.
Facultative selenium accumulator plants do not require
high selenium for survival but can accumulate high
selenium. Obligate selenium accumulator plants can
store selenium at concentrations of 3000 to 10 000 mg kg-1
selenium on a dry weight basis (Freeman et al., 2006),
while facultative accumulator plants can contain several
hundred to several thousand mg kg-1, and non-accumulator
plants growing on the same soil may contain from ten
to occasionally a few hundred mg kg-1. The majority
of selenium in accumulator plants is found as organic
methyl-selenocysteine and selenocystathionine or
as inorganic selenate (Shrift and Virupaksha, 1965;
Underwood and Suttle, 1999; Pickering et al., 2003;
Freeman et al., 2006). The selenium in most plants that
grow on normal soils contains <3 mg Se/kg with the
predominant forms of selenium being selenate and
selenomethionine (Whanger, 2002). Several chemical
forms have been reported in non-indicator plants
growing on high selenium soils.
Inorganic forms of selenium are the primary form in
soil. Only the water soluble forms are readily available
for plant uptake, with the greatest absorption being in the
form of selenate via the sulfate transporter. Elemental
selenium and precipitated metal-selenides are not
bioavailable for plant uptake.
Briefly, about selenium metabolism in plants we
should note that selenate for both accumulator and non-
accumulator plants is less toxic and is absorbed to a
greater extent than selenite, which is most toxic to the
non-accumulator plants, the grains and grasses.
SELENIUM TOXICITY IN ANIMALS 
Selenium toxicity in livestock is invoked by ingestion
of both primary and secondary selenium accumulator
plants containing moderate to high levels of selenium.
Toxicity is manifested, as previously noted, in “alkali
and blind staggers diseases.” Experimental chronic
selenium toxicity in animals is known to affect the
major organs including the liver, spleen, kidneys, heart,
and pancreas. Multiple factors contribute to chronic
experimental selenium toxicity including animal species,
dietary selenium compound administered, quality of
dietary protein, dietary acclimation, and of course, dietary
selenium concentration.
Experimental selenium toxicity has been most
widely studied in rodents, but it has also been studied
in other species of animals (Muth et al., 1967; Cooper
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and Glover, 1974; Oldfield, 1987). Selenium toxicity in
humans is rare, yet it occurs with symptoms similar to
those found in animals (Combs et al, 1987; neve and
Favier, 1989). In the rat, the dietary requirement for
selenium is ca. 0.20 mg kg-1 (Hafeman et al., 1974).
The threshold for selenium toxicity from selenite is about
0.50 mg kg-1, a mere 2.5 times the dietary requirement
(Tinsley et al., 1967). Chronic dietary selenite toxicity
in the rat begins at 3–4 mg kg-1 and there is almost no
survival of rats fed 16 mg kg-1 Se (Harr et al., 1967).
Chronic ingestion of either selenite or selenate in the
rat, at the same selenium dietary levels, exhibits nearly
equivalent toxicity (Brasher and Ogle, 1993; Wilber,
1993). Dietary ingestion of organoselenium compounds,
however, exhibit wide differences in toxicity.
In comparison to selenite, on an equivalent selenium
basis, selenocystine toxicity is approximately equal to
that of selenite (Martin and Hurlbut, 1976). Seleno-
methionine is less toxic than selenite with the L-isomer
being only slightly more toxic than the D-isomer (Stewart
et al., 1986; Choy et al., 1993). Se-methylselenocysteine,
the nonproteinaceous amino acid found in selenium
accumulator plants, exhibits reduced or delayed toxicity
in mice (Martin and Hurlbut, 1976). Other selenoethers,
dimethylselenide, trimethyselenonium ion, and seleno -
betaine are not very toxic in comparison to selenite
(McConnell and Portman, 1952; Ip and Ganther, 1992).
WHY IS SELENIUM TOXIC?
1.  Selenium compounds, i.e., selenite and selenium
dioxide, can react with glutathione (GSH) and other
thiols to form selenotrisulfides that will ultimately
react to produce superoxide and hydrogen peroxide,
and are toxic. 
2.   Diselenides, i.e., selenocystine and selenocystamine
in the presence of GSH and other thiols, are reduced
to selenols (RSeH), which are catalytic, produce su-
peroxide and hydrogen peroxide, and are toxic.
3.  Selenium compounds that do not react with thiols,
i.e., selenate and all tested selenoethers (RSeR), do
not produce superoxide or hydrogen peroxide in
vitro and are not toxic per se. 
4.   Selenate and selenoethers are toxic in tissue culture
or in vivo only after being reduced to selenite or a
selenol. 
5.   Selenium toxicity manifests itself acutely or chronically
when oxidative damage exceeds antioxidant defenses
or the ability of either plants or animals to form seleno -
proteins, selenoethers, or elemental selenium (Se0)
(Spallholz, 1994). 
SELENIUM NUTRITIONAL TOXICITY
Different chemical forms of selenium are highly
toxic. From a nutritional aspect, systemic toxicity implies
that selenium is bioavailable from the chemical form under
consideration, which is the case for selenite, selenate and
selenoamino acids, i.e. selenomethionine (Se-methionine)
and Se-cystine (Levander, 1983). Sodium selenite is resorbed
by passive diffusion, while the absorption of sodium
selenate from the intestinal brush border is an active
transport, where the corresponding sulfur compounds can
compete (Arduser et al., 1985; Wolffram et al., 1988;
Wolffram, 1995). The rate-limiting step for the bio -
availability of selenium, however, is not the rate of
resorption, but the conversion into a metabolically active
form (Contempre et al., 1996). First of all, in an intracellular
environment, sodium selenite undergoes a spontaneous
reaction with abundantly present reduced glutathione
to form seleno-diglutathione with a stoichiometry of
1:4 between selenite and glutathione (Ganther, 1968).
In a secondary reaction, seleno-diglutathione is
converted to seleno persulﬁde (GSSeH) that either
decays spontaneously to elementary selenium and
glutathione or is enzymatically converted under anaerobic
conditions to hydrogen selenide (H2Se) (Hsieh and
Ganther, 1975). This central selenide pool serves either
as the basis for methylated derivates that are excreted
or as a donor for conversion into hydrogen selenide,
which is the common precursor for further metabolism
into Se-cysteine (Ganther, 1966; Mozier et al., 1988;
Ip et al., 1991; Berry et al., 1993; Guimaraes et al., 1996).
In contrast to Se-cysteine, mammalian organisms are
unable to synthesize Se-methionine (Levander and
Burk, 1986). Conversely, Se-methionine uses the trans -
sulfuration pathway of the sulfur amino acids and thus
can be converted into Se-cyst(e)ine (Beilstein and
Whanger, 1992). 
The toxicity of selenium is known for a long time, and
the acute toxicity of organic and inorganic resorbed
selenium compounds has an LD50 in the range of
2–5 mg kg-1 (Combs and Combs, 1986).
SELENIUM CARCINOSTATIC TOXICITY
As an essential nutrient, Se affects the functions of
several specific intracellular selenoproteins as an
essential constituent of selenocysteine (Se–Cys).
Epidemiological studies indicate that Se deficiency
can induce several diseases in humans. Se plays a vital
role as an antioxidant in humans. Considering its impor-
tance for humans, the recommended dietary intake for
Se is 55 and 30 μg day-1 for healthy adults in the US
and Europe and 50–250 μg day-1 for adults in China
by Chinese nutrition Society (Sun et al., 2014).
The anticarcinogenic nature of Se has been investigated
for several decades. However, researchers found that there
is an inverse relationship between Se content and cancer
risk. For example, Whanger (2004) reported that Se doses
at 100–200 μg day-1 inhibit genetic damage and cancer
development in humans; however, at ≥400 μg day-1,
Se probably induces cancer (Zeng and Combs, 2008).
Although excessive Se can induce cancer in humans,
the relation between Se and cancer is still unclear.
Figure 1 shows high Se can induce carcinogenesis,
cytotoxicity and genotoxicity. 
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CONCLUSION
It seems that recognition of selenium compounds
that produce superoxide and hydrogen peroxide, fully
accounts for the toxicity and carcinostatic/cytotoxic ac-
tivity of selenium compounds. Also, results reveal se-
lenium carcinostatic activity normally occurs only at
dietary levels that approach systemic selenium toxicity.
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Figure 1: Selenium toxicity in humans and rats
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